Pharmaceutical Investments and Alzheimer's Research

This chapter explores the financial motivations for pharmaceutical companies to invest in Alzheimer's drug research, including profitability assessments and the challenges of FDA approval. It highlights the importance of public funding from organizations like the NIH in supporting vital research that may not attract private investment.